Report

  1. Home
  2. Discounted reports

North America Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

Market Report I 2022-11-24 I 169 Pages I The Insight Partners
Discounted by 30% to 2024-06-30

The embolotherapy market in North America is expected to grow from US$ 1,354.02 million in 2022 to US$ 2,245.73 million by 2028. It is estimated to grow at a CAGR of 8.8% from 2022 to 2028.

Rising Preference for Minimally Invasive Procedures Drives Growth of Embolotherapy Market in North America Patients increasingly prefer minimally invasive surgeries due to their various advantages such as low postoperative pain, less postoperative complications, short hospital stays, and fast recovery times. Trans Arterial Chemo Embolization (TACE) is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma. TACE is used for patients suffering from asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-catheter Arterial Embolization (TAE). Bleeding is a common issue in cancer patients, related to local tumor invasion, tumor angiogenesis, systemic effects of cancer, and anti-cancer treatments. TACE involves a two-step process-selective arterial occlusion restricts the blood supply to the tumor, which causes ischemic tumor necrosis, and regional chemotherapy helps the drug remain in the area for a prolonged period, which starts causing the therapeutic effects. Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolotherapy market growth in North America.

Market Overview
The North America embolotherapy market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021, owing to the growing prevalence of hepatocellular cancer and liver cancer coupled with the increasing focus of the major manufacturers on technological advancements. Furthermore, the advanced healthcare sector of the region, the prevalence of sophisticated technological healthcare facilities. The embolotherapy market in the region is anticipated to grow significantly in the coming years owing to the rising cases of brain aneurysms. According to the Brain Aneurysm Foundation's report, ~6 million people have unruptured brain aneurysms in the US. Also, the annual rate of rupture is nearly 8-10 per 100,000 people; ~30,000 people in the country suffer from a brain aneurysm rupture. In addition, about 4 out of 7 people who recover from a ruptured brain aneurysm are likely to suffer from the disabilities. This neurological disorder generally affects people who are in the age group of 35-60 years. However, the brain aneurysm can also be seen in children, and women in the country suffer more than men.
North America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

North America Embolotherapy Market Segmentation

The North America embolotherapy market is segmented on the basis of product, disease indication, procedure, end user, and country.
Based on product, the North America embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents segment held a larger market share in 2022. Based on disease indication, the North America embolotherapy market is segmented into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. Based on procedure, the North America embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. Based on end user, the North America embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the North America embolotherapy market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022. Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, Balt USA LLC, Stryker Corporation, Guerbet LLC, and Terumo Corporation are among the leading companies operating in the embolotherapy market in North America.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Embolotherapy Market - by Product
1.3.2 North America Embolotherapy Market - by Disease Indication
1.3.3 North America Embolotherapy Market - by Procedure
1.3.4 North America Embolotherapy Market - by End User
1.3.5 North America Embolotherapy Market- By Country
2. North America Embolotherapy Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Embolotherapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. North America Embolotherapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Burgeoning Incidence of Cancer Cases
5.1.2 Boosting Patient Preference for Minimally Invasive Procedures
5.2 Market Restraints
5.2.1 Availability of Other Alternative Therapies
5.3 Market Opportunity
5.3.1 Elevating Applications of Embolotherapy
5.4 Market Trend
5.4.1 Widening Use of Liquid Embolic Agents
5.5 Impact analysis
6. North America Embolotherapy Market Analysis
6.1 North America Embolotherapy Market Revenue Forecast and Analysis
7. North America Embolotherapy Market - by Product
7.1 Overview
7.2 North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
7.3.1 Overview
7.3.2 Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.3 Microspheres
7.3.3.1 Overview
7.3.3.2 Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.4 Embolic Coils
7.3.4.1 Overview
7.3.4.2 Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.5 Embolic Plug Systems
7.3.5.1 Overview
7.3.5.2 Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.6 Detachable Balloons
7.3.6.1 Overview
7.3.6.2 Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.7 Liquid Embolic Agents
7.3.7.1 Overview
7.3.7.2 Liquid Embolic: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
7.4.1 Overview
7.4.2 Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4.3 Microcatheters
7.4.3.1 Overview
7.4.3.2 Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4.4 Guidewires
7.4.4.1 Overview
7.4.4.2 Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
8. North America Embolotherapy Market Analysis - by Disease Indication
8.1 Overview
8.2 North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Liver Cancer
8.3.2.1.1 Overview
8.3.2.1.2 Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Kidney Cancer
8.3.2.2.1 Overview
8.3.2.2.2 Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Other Cancers
8.3.2.3.1 Overview
8.3.2.3.2 Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
8.4.1 Overview
8.4.2 Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
8.5.1 Overview
8.5.2 Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
8.6.1 Overview
8.6.2 Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
8.7.1 Overview
8.7.2 Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Embolotherapy Market Analysis - by Procedure
9.1 Overview
9.2 North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
9.3.1 Overview
9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
9.4.1 Overview
9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
9.5.1 Overview
9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Embolotherapy Market Analysis - By End User
10.1 Overview
10.2 North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11. North America Embolotherapy Market - Country Analysis
11.1 North America Embolotherapy Market
11.1.1 North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.1.1.1 US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2 US Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.1 US Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.2 US Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 US Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3.1 US Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 US Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 US Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2 Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.1 Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.2 Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3.1 Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2 Mexico Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.1 Mexico Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.2 Mexico Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 Mexico Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3.1 Mexico Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 Mexico Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 Mexico Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
12. Embolotherapy Market -Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medtronic
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Acandis GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Balt USA LLC
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Stryker Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guerbet LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Terumo Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1. US Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 7. US Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 22. Organic Developments Done by Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms, North America Embolotherapy Market



LIST OF FIGURES

Figure 1. North America Embolotherapy Market Segmentation
Figure 2. North America Embolotherapy Market, By Country
Figure 3. North America Embolotherapy Market Overview
Figure 4. Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market
Figure 5. Embolotherapy Market in North America to Show Remarkable Growth During Forecast Period
Figure 6. North America Embolotherapy Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. North America Embolotherapy Market Impact Analysis of Drivers and Restraints
Figure 9. North America Embolotherapy Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
Figure 11. Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 13. Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 14. Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 15. Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Embolic: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 18. Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 19. Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 20. Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
Figure 22. Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
Figure 32. Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
Figure 36. Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 40. North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 41. US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3000.00 $2100.00
  • $4000.00 $2800.00
  • $5000.00 $3500.00
  • ADD TO BASKET
  • BUY NOW